Research Priorities for Heart Failure With Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group Summary.
Sanjiv J Shah, Barry A Borlaug, Dalane W Kitzman...
https://pubmed.ncbi.nlm.nih.gov/32202936Actively Recruiting
Led by University of Nebraska · Updated on 2026-01-16
300
Participants Needed
3
Research Sites
4 weeks
Total Duration
Researchers are studying adults with heart failure with preserved ejection fraction (HFpEF) to understand how different exercise coaching methods affect their ability to exercise, improve symptoms, and change blood markers. The study compares three groups over 18 months: usual care with video exercises, in-person coaching with exercise, and virtual coaching via videoconference. The goal is to see which method helps patients stick to exercise routines and improves their health and physical function. Participants are randomly assigned to one of three groups: the usual care group accesses exercise videos online and does not meet with a coach; the HEART Camp group exercises and meets with a coach in person at a medical fitness center; and the HEART Camp Connect group exercises using videos and meets virtually with a coach. Coaching sessions occur weekly for the first 3 months and then every other week up to 12 months, with group exercise and Q&A sessions on alternate weeks. After 12 months, coaching ends, and participants manage their exercise independently for the final 6 months. Participants undergo an initial exercise test to ensure safety and receive training on using activity monitors, heart rate monitors, and exercise diaries. They wear activity monitors for 7 days at four study points (baseline, 6, 12, and 18 months), have blood drawn, complete a 6-minute walk test, and fill out questionnaires about heart failure and exercise. The study measures exercise adherence over time and tracks heart failure symptoms, physical function, inflammatory blood markers, and quality of life. The total participation lasts 18 months with regular monitoring and data collection.
CONDITIONS
HEART Camp Connect -Promoting Exercise in Adults With Heart Failure With Preserved Ejection Fraction
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for cardiopulmonary exercise testing (CPET) and safety evaluation
Duration - Approximately 1 week
Participants complete 3 monitored cardiac rehabilitation sessions and study orientation including training on exercise platforms and monitoring devices.
3 monitored sessions and 1 in-person orientation visit
Duration - 12 months
Participants engage in a 12-month exercise intervention with coaching. The HEART Camp group meets in-person; the HEART Camp Connect group meets virtually. Coaching frequency tapers over time with weekly sessions for 3 months and biweekly sessions with group training until month 12. The Enhanced Usual Care group receives virtual access and support without coaching.
Weekly 30-minute coaching sessions Months 1-3; every other week 15-minute coaching plus alternate week 1-hour group sessions Months 4-12
Duration - 6 months
Participants self-regulate exercise without coaching or motivational messages for 6 months after the intervention ends.
No scheduled coaching visits; participants continue exercise independently
Duration - Throughout study duration
Participants meet with research staff at baseline, 6, 12, and 18 months for assessments including blood draws, 6-minute walk tests, activity monitoring, and surveys.
4 visits (in-person) at baseline, 6, 12, and 18 months
Total: 3 locations
1
Henry Ford Health System
Detroit, Michigan, United States, 49201
Actively Recruiting
2
University of Nebraska Medical Center
Omaha, Nebraska, United States, 68198-5330
Actively Recruiting
3
University of Virginia
Charlottesville, Virginia, United States, 22903
Not Yet Recruiting
W
Windy W Alonso, PhD
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Sanjiv J Shah, Barry A Borlaug, Dalane W Kitzman...
https://pubmed.ncbi.nlm.nih.gov/32202936Salim S Virani, Alvaro Alonso, Hugo J Aparicio...
https://pubmed.ncbi.nlm.nih.gov/33501848John J V McMurray, Stamatis Adamopoulos, Stefan D Anker...
https://pubmed.ncbi.nlm.nih.gov/22611136Jerome L Fleg, Lawton S Cooper, Barry A Borlaug...
https://pubmed.ncbi.nlm.nih.gov/25605639Ambarish Pandey, Akhil Parashar, Dharam Kumbhani...
https://pubmed.ncbi.nlm.nih.gov/25399909Bunny J Pozehl, Kathleen Duncan, Melody Hertzog...
https://pubmed.ncbi.nlm.nih.gov/25433674Bunny J Pozehl, Rita McGuire, Kathleen Duncan...
https://pubmed.ncbi.nlm.nih.gov/30010027Shane Warehime, Danae Dinkel, Windy Alonso...
https://pubmed.ncbi.nlm.nih.gov/32861888Windy W Alonso, Kevin Kupzyk, Joseph Norman...
https://pubmed.ncbi.nlm.nih.gov/33580663Joseph F Norman, Kevin A Kupzyk, Nancy T Artinian...
https://pubmed.ncbi.nlm.nih.gov/31373222